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Introduction
Left atrial appendage (LAA) device closure is an alternative 
treatment to oral anticoagulation in patients who are unsuit-
able for anticoagulation therapy. The 2014 American Heart 
Association/American Stroke Association guidelines suggest 
the role of LAA device closure as an alternative strategy for 
stroke prevention in atrial fibrillation (AF) patients at high 
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risk of stroke who are poor candidates for oral anticoagula-
tion.1) In some patients, peri-device leakage of the LAA per-
sists due to incomplete occlusion, although the procedure’s 
success rate is generally high.2-4) However, information regard-
ing the presence of and factors contributing to peri-device 
leakage is scarce, and further study to evaluate the anatomical 
and procedure-related factors of this leakage has not been per-
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Background: After left atrial appendage (LAA) device closure, peri-device leakage into the LAA persists due to incomplete 
occlusion. We hypothesized that pre-procedural three-dimensional (3D) geometric analysis of the interatrial septum (IAS) and LAA 
orifice can predict this leakage. We investigated the predictive parameters of LAA device closure obtained from baseline cardiac 
computerized tomography (CT) using a novel 3D analysis system.
Methods: We conducted a retrospective study of 22 patients who underwent LAA device closure. We defined peri-device leak-
age as the presence of a Doppler signal inside the LAA after device deployment (group 2, n = 5) compared with patients without 
peri-device leakage (group 1, n = 17). Conventional parameters were measured by cardiac CT. Angles θ and φ	were defined between 
the IAS plane and the line, linking the LAA orifice center and foramen ovale.
Results: Group 2 exhibited significantly better left atrial (LA) function than group 1 (p = 0.031). Pre-procedural θ was also 
larger in this group (41.9° vs. 52.3°, p = 0.019). The LAA cauliflower-type morphology was more common in group 2. Overall, 
the patients’ LA reserve significantly decreased after the procedure (21.7 mm3 vs. 17.8 mm3, p = 0.035). However, we observed no 
significant interval changes in pre- and post-procedural values of θ and φ in either group (all p > 0.05).
Conclusion: Angles between the IAS and LAA orifice might be a novel anatomical parameter for predicting peri-device leakage 
after LAA device closure. In addition, 3D CT analysis of the LA and LAA orifice could be used to identify clinically favorable can-
didates for LAA device closure.
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formed. Left atrium (LA) and LAA geometry is complex; there-
fore, only limited data are available for predicting procedural 
success based on cross-sectional imaging surrogates. The rela-
tive location of the LAA orifice to the interatrial septum (IAS) 
varies, and these differences may affect the success rate of de-
vice implantation.5)
We hypothesized that three-dimensional (3D) anatomical 
imaging of the relative locations of the IAS and LAA orifice 
could predict peri-device leakage after LAA device closure. How-
ever, no data exist on the outcome after LAA device closure link-
ing these anatomical relationships. We also hypothesized that 
reverse remodeling of LA and functional recovery after closure 
could impact the occurrence of post-procedural complication.
Therefore, we aimed to investigate the predictive parameters 
of LAA device closure obtained from baseline cardiac comput-
erized tomography (CT) imaging using a novel 3D analysis sys-
tem. We also explored if changes in cardiac geometry and func-
tion after LAA device closure correlate with procedural success.
Methods
Study population
We conducted a retrospective, observational study. Thirty-
one patients who had undergone LAA device closure at Sever-
ance Cardiovascular Hospital, Yonsei University, were con-
secutively enrolled in the Yonsei LAA Occluder Registry from 
October 2010 to April 2014. Among them, nine patients who 
had not undergone pre- and post-procedural cardiac CT imag-
ing were excluded. Thus, 22 patients were enrolled in this study, 
14 of which received a WATCHMAN device (Boston Scientif-
ic, Natick, MA, USA) and 8 of which received Amplatzer car-
diac plugs (ACPs) device (St. Jude Medical, Menneapolis, 
MN, USA) (Fig. 1). The clinical, procedural, and echocardio-
graphic outcome variables of these patients were retrospective-
ly reviewed and analyzed. All patients had AF with high risk 
for stroke (CHADS2 score ≥ 2 or CHA2DS2-VASc score ≥ 2)
6)7) 
and bleeding or contraindication to anticoagulation. Exclusion 
criteria for LAA device closure were as follows: 1) LAA throm-
bus or 2) active endocarditis.
Traditional or novel oral anticoagulation therapy was contin-
ued in the patients with the WATCHMAN device for 3 months 
post-procedure. Anticoagulation medication was discontinued 
at time of discharge in patients with ACP. Procedural success 
was defined as successful implantation of the device in the LAA 
without any complication, such as pericardial effusion, tam-
ponade, peri-device leakage, or stroke. The study protocol was 
approved by the Institutional Review Board of Severance Car-
diovascular Hospital, Seoul, Korea and complied with the Dec-
laration of Helsinki, and written informed consents were ob-
tained from all study participants.
Pre-, peri-, and post-procedural 
transesophageal echocardiography
All patients underwent pre-procedural transesophageal 
echocardiography (TEE) with a Philips iE33 machine (Philips 
Medical System, Andover, MA, USA) equipped with a multi-
plane probe X7-2t to detect possible LAA thrombi and mea-
sure the LAA orifice diameter as described previously.8) Two-
dimensional-TEE images were obtained every 30°. Based on 
these images, a WATCHMAN device 10–20% larger than the 
LAA diameter and lobe sizes of ACP 3–5 mm larger than the 
landing zone diameter were selected to ensure stable device 
positioning.9)10) We also measured the LAA orifice diameter 
and landing zone using cardiac CT as described at the next 
paragraph. In the case of different measurements between pre-
procedural TEE and cardiac CT, the largest size was chosen. 
The procedure was performed under general anesthesia, and 
TEE was performed during the full procedure. After transsep-
tal puncture, a delivery catheter was advanced to approach the 
LAA, and the selected device was implanted. Device placement 
into the LAA was perpendicular to the LAA landing zone axis 
(ACP), or the device was advanced until both of its distal mark-
er bands and access sheath were aligned (WATCHMAN). In-
travenous heparin was administered to maintain an activated 
clotting time of > 250 sec until completion of the procedure.
Follow-up transthoracic echocardiography was performed 
within 1 day to detect device embolization or pericardial effu-
sion after the procedure. Follow-up TEE was performed 2 or 3 
months after the procedure to monitor the presence of residual 
peri-device flow between the LAA and LA, detect thrombi on 
the device, and determine device stability and positioning. Pres-
ence of a Doppler signal inside the LAA after device deploy-
ment indicated leakage (Fig. 2). The severity of peri-device flow 
was defined as minor (jet width < 1 mm), moderate (1 mm to 
3 mm), or major (> 3 mm).
Characterization of LA and LAA via 
conventional CT imaging
All patients underwent pre-procedural cardiac CT to measure Fig. 1. Flow diagram of the study population. LAA: left atrial appendage.
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the LAA orifice diameter and evaluate the LAA morphology. 
Cardiac CT of each patient was performed with multiple-de-
tector CT (320-detector CT, Aquilion®; Toshiba Medical Sys-
tem Corporation, Otawara, Japan), and images were analyzed 
using commercially available post-processing software (Vit-
rea®, Vital Images, Toshiba Medical System Corporation, Ota-
wara, Japan). We measured LA volume, ostium diameter, and 
orifice area and subsequently calculated LA reserve and func-
tion. Maximal and minimal LA and LAA volumes were mea-
sured with acquired images at 30% and 70% of the R-R inter-
val, respectively, from which LA reserve and LA/LAA function 
was calculated. The reserve was determined by subtracting the 
minimal volume from the maximal volume, and function was 
expressed as a percentage of the reserve calculation.
The LAA morphology of each patient was classified into one 
of four groups as described previously:11)12) 1) wind sock: one 
dominant lobe of sufficient length plus secondary or tertiary 
lobes arising from the dominant lobe, 2) chicken wing: a sharp 
bend in the proximal or medial part of the dominant lobe at 
some distance from the perceived LAA ostium, 3) cactus: a dom-
inant central lobe with small chambers extending in all direc-
tions, or 4) cauliflower: complex internal characteristics with 
no dominant lobe.
Follow-up cardiac CT was also performed 2 or 3 months after 
the procedure to evaluate the change of LA/LAA function, re-
serve and geometry.
Measuring the angle between the IAS and LAA 
orifice with novel software
We developed a 3D software system to measure the angle 
between the IAS and LAA orifice based on Visual Studio C++ 
2008 (Microsoft, Seattle, WA, USA). We defined one plane (IAS 
plane) with three points (P, A, and U) to measure the angles (θ, 
φ) between the IAS and LAA with a 3D approach (Fig. 3). At 
first, the point L was chosen at the center of the LAA orifice 
(Fig. 4A and B). P is the foramen ovale, which is usually as-
sessed as an IAS puncture site (Fig. 4C, D, and E), and A is de-
fined as the point at which the aortic root and IAS plane are 
aligned in oblique view (Fig. 4D and E). U is an arbitrary point 
that lies on the IAS (Fig. 4D). All points were manually se-
lected in oblique view. We defined a→ as the vector from P to A, 
and u→ as the vector from P to U. The plane n→, the normal vec-
tor which represents the IAS plane, is given as the outer prod-
uct of a→ and u→, which can be written as a→ × u→ = n→. Hence, the 
vector l
→
 = L - P can be specified with two parameters, θ and φ, 
in the spherical coordinate system. Both θ and φ can be mea-
sured as the inner products of n→·l
→
 and a→·l
→
’ respectively, and 
l
→
’ is the projected vector l
→
 onto IAS plane (Fig. 3). θ is the angle 
between vector n→ and l
→
, and φ is the angle between vector a→ and 
the projected vector l
→
 onto IAS plane. Then, two angles were 
defined: 1) θ, the angle between the IAS plane and the line, 
linking the LAA orifice center and the foramen ovale, and 2) φ, 
the angle between the IAS and the LAA orifice center. These 
two values were calculated with four coordinate values using the 
new software. We defined another coordinate system (a, y, n) 
from the given points (P, U, and A), and suggested the formu-
Fig. 2. Peri-device leakage identified by transesophageal echocardiography (TEE) color Doppler imaging. The TEE image shows incomplete device 
sealing with residual flow of 4 mm. The average flow rate was 10 cm/sec.
Fig. 3. A spherical coordinate system illustrates three dimensional 
image space where the vector direction of the LAA center is specified by 
two numbers. To measure the angles (θ, φ) between the IAS and LAA 
with a 3D approach, we defined one plane (IAS plane) with three points: 
the foramen ovale (P), an arbitrary point on IAS plane (U), a defined 
point at the intersection of aortic root and IAS plane (A) and the center 
of LAA orifice (L). LAA: left atrial appendage, IAS: interatrial septum, 3D: 
three-dimensional.
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las to calculate θ and φ as described (Supplementary Fig. 1). 
Total time required to measure and calculate these two angles 
per one study was within 10 minutes. 
Statistical analysis
Continuous variables are presented as the median (25th, 
75th percentiles) due to the non-parametric model, and cate-
gorical variables are presented as numbers (%). For compari-
Table 1. Baseline characteristics of study participants
No peri-device leakage (group 1, n = 17) Peri-device leakage (group 2, n = 5) p value
Age, years 0.61 (54, 70) 0.70 (52, 81) 0.087
Female, n (%) 0.06 (27.3) 0.01 (20.0) 0.519
Hypertension, n (%) 0.16 (72.7) 0.05 (100.0) 0.999
Diabetes, n (%) 0.08 (36.4) 0.02 (40.0) 0.999
Previous stroke, n (%) 0.07 (41.2) 0.03 (60.0) 0.624
Dyslipidemia, n (%) 0.08 (36.4) 0.02 (40.0) 0.999
CAD, n (%) 0.07 (31.8) 0.02 (40.0) 0.999
Complications, n (%)
Pericardial effusion 0.01 (5.9) 0.01 (20.0) 0.411
Stroke 0.01 (5.9) 0.01 (20.0) 0.411
Echocardiographic parameters
LAVI, mm3/m2 68.6 (44.7, 84.2) 52.5 (41.0, 59.9) 0.301
LA-AP diameter, mm 54.2 (46.0, 84.2) 48.0 (43.0, 54.0) 0.314
LV EDD, mm 51.0 (48.3, 50.5) 47.3 (39.0, 54.0) 0.659
LV ESD, mm 35.3 (31.0, 33.0) 32.0 (25.0, 35.0) 0.825
LV EF, % 0.62 (58, 69) 0.64 (59, 69) 0.983
LAA emptying velocity, cm/msec 21.8 (15.8, 26.9) 21.0 (13.5, 31.5) 0.309
CAD: coronary artery disease, LAVI: left atrial volume index, LA-AP: left atrium-anteroposterior, LV: left ventricle, EDD: end-diastolic diameter, ESD: end-sys-
tolic diameter, EF: ejection fraction, LAA: left atrial appendage
Fig. 4. The program was developed to measure the angle between the interatrial septum and left atrial appendage (LAA) orifice. In a real CT volume 
image, four points were defined to calculate the angle between the interatrial septum and LAA orifice: the center of LAA orifice (the point with thick 
arrows at A and B), the foramen ovale (the point with thick arrows at C, D, and E), an arbitrary point (the point with short thin arrow at D) and a defined 
point (point with long thin arrows in D and E).
A B
DC E
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son of continuous variables among groups, a Kruskall-Wallis 
test was performed. The chi-square test was performed for com-
paring categorical variables. Analysis was performed with the 
statistical software SPSS 20.0 for Windows (IBM, Markham, 
Canada). A two sided p-value of < 0.05 indicated statistical sig-
nificance.
Results
Patient characteristics
Of the 22 study participants, 16 patients (31.8%) were wom-
en, and the median age of the study group was 63 (54, 71) years. 
Baseline characteristics are presented in Table 1. Severe peri-de-
vice leakage occurred in 5 patients (22.7%), either immediately 
after device implantation or during the follow-up period. Three 
patients (13.6%) experienced intraprocedural peri-device leak-
age, and 2 subjects (9.1%) without intraprocedural leakage 
showed newly developed leakage at their 2–3 month follow-
up. Patients were divided into two groups: group 1, without 
peri-device leakage (n = 17) and group 2, with peri-device leak-
age (n = 5). We observed no significant differences in the pres-
ence of hypertension, diabetes, age, and gender between the two 
groups. Conventional echocardiographic parameters such as 
left ventricular ejection fraction, LA volume index, and LAA 
emptying velocity were similar between the two groups.
The device was implanted in all 22 patients without embo-
lization, and immediate procedural success rate was 77.3% 
(17/22). Two patients developed peri-procedural pericardial 
effusion without cardiac tamponade, and two patients experi-
enced post-procedural stroke. Warfarin was discontinued in 
ten WATCHMAN patients (10/14, 71.4%) after a 2–3 month 
follow-up TEE and in six ACP patients (6/8, 75.0%) at dis-
charge. In patients without peri-device leakage, two patients 
continued taking warfarin because of renal infarction (1 pa-
tient) or post-procedural stroke (1 patient).
Table 2. Pre-procedural computerized tomography findings
No peri-device leakage (group 1, n = 17) Peri-device leakage (group 2, n = 5) p value
LAA orifice maximal diameter, mm 030.2 (25.6, 33.7) 031.2 (27.6, 34.8) 0.880
LAA orifice minimal diameter, mm 021.8 (19.7, 24.8) 022.7 (20.3, 25.6) 0.412
LAA orifice circumference, mm 083.9 (73.6, 95.7) 087.3 (76.6, 98.9) 0.704
LAA orifice area, mm2 576.6 (452.8, 740.0) 504.5 (409.5, 664.5) 0.316
LAA maximal volume, mm3 016.2 (9.9, 20.5) 016.3 (10.3, 23.0) 0.864
LAA minimal volume, mm3 013.2 (8.5, 17.0) 013.4 (7.0, 23.3) 0.620
LAA function, % 017.9 (8.6, 22.3) 021.9 (4.5, 42.1) 0.897
LA maximal volume, mm3 194.5 (147.5, 237.0) 157.2 (131.0, 189.4) 0.168
LA minimal volume, mm3 172.6 (123.0, 220.0) 125.3 (111.3, 144.0) 0.144
LA reserve, mm3 022.0 (12.2, 17.0) 020.5 (7.6, 30.4) 0.818
LA function, % 011.3 (6.3, 13.7) 017.0 (14.7, 20.9) 0.031
θ° 041.9 (37.6, 41.9) 052.3 (44.2, 58.8) 0.019
φ° 006.0 (-4.8, 17.7) 019.1 (10.6, 30.9) 0.109
LAA morphology, n (%)
Chicken wing 00.09 (52.9) 00.01 (20.0)
0.254Wind sock 00.02 (11.8) 00.00 (0.0)
Cauliflower 00.06 (36.3) 00.04 (80.0)
LA: left atria, LAA: left atrial appendage, IAS: interatrial septum, θ: the angle between the IAS plane and the line, linking the LAA orifice center and the fora-
men ovale, φ: the angle between the IAS and the LAA orifice center
Table 3. Post-procedural computerized tomography findings
No peri-device leakage (group 1, n = 17) Peri-device leakage (group 2, n = 5) p value
LA maximal volume, mm3 180.0 (130.4, 201.2) 158.8 (107.2, 237.3) 0.611
LA minimal volume, mm3 161.7 (117.6, 150.1) 143.6 (95.4, 208.7) 0.704
LA reserve, mm3 018.4 (8.6, 24.3) 015.2 (5.1, 28.5) 0.611
LA function, % 010.1 (4.4, 13.1) 009.0 (3.9, 12.0) 0.611
θ° 043.8 (39.5, 48.8) 052.9 (45.8, 63.8) 0.121
φ° 005.0 (-10.9, 16.4) 020.2 (9.4, 28.4) 0.121
LA: left atria, LAA: left atrial appendage, IAS: interatrial septum, θ: the angle between the IAS plane and the line, linking the LAA orifice center and the foramen 
ovale, φ: the angle between the IAS and the LAA orifice center
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Pre-procedural cardiac CT findings
Pre-procedural cardiac CT findings are presented in Table 2. 
We observed no significant difference in LAA orifice diameter 
or LAA volume and function between the two groups. How-
ever, LA function was better in group 2 than group 1 [11.3% 
(6.3, 13.7) vs. 17.0% (14.7, 20.9), p = 0.031]. In addition, pre-
procedural θ was larger in group 2 [41.9° (37.6, 41.9) vs. 52.3° 
(44.2, 58.8), p = 0.019]. Cauliflower-type morphology was 
more common in group 2 (80.0% vs. 35.3%), but the chicken 
wing type was more common in group 1 (52.9% vs. 20.0%).
Post-procedural cardiac CT findings
Post-procedural cardiac CT findings are shown in Table 3. We 
saw no significant difference in LA volume or function between 
group 1 and group 2. We also observed no significant interval 
change between pre- and post-procedural LA function [12.4% 
(7.5, 15.4) vs. 9.9% (4.3, 12.7), p = 0.135], but LA reserve 
significantly decreased after the procedure [21.7 mm3 (12.2, 
30.0) vs. 17.8 mm3 (8.4, 26.2), p = 0.035]. In contrast, we saw 
no significant difference between groups 1 and 2 with respect 
to post-procedural θ and φ or pre- and post-procedural interval 
changes (all p > 0.05).
Discussion
Implanting an LAA device by making a separate transseptal 
puncture in the inferoposterior direction is generally preferred 
to provide more direct vector orientation to access the LAA.13)14) 
However, using 3D geometry characterization to predict peri-
device leakage has not been well studied. Here, we developed 
a novel mathematical approach to accurately measure the 3D 
relationship between the IAS and LAA orifice planes. We found 
that angulation between the planes significantly affected proce-
dural results, such as development of peri-device leakage. Thus, 
we propose pre-procedural individualized catheter selection, 
manual shaping of the puncture needle, and/or adjustment of 
the IAS puncture angle according to pre-operative 3D anatom-
ical characterization to limit these post-operative complications.
Novel 3D measurements of LAA geometry
Geometric complexity, individual variation in LAA morphol-
ogy, or mismatch between the device shape and LAA morphol-
ogy may result in incomplete occlusion with a gap between the 
device and LAA, causing peri-device leakage.4)11)15)16) The de-
vice is implanted via a transseptal route into the LAA orifice, 
and the resulting angle might be related to device stability, po-
sitioning, and possible leakage. However, current imaging 
methods cannot accurately measure this angle. Therefore, we 
designed a new program to measure the angle using one plane 
and one point and evaluated the anatomical relationship of the 
IAS and LAA orifice, which could significantly impact com-
plete LAA device occlusion.
Among the four LAA morphological types, the cauliflower 
type is most often associated with peri-device leakage and an 
embolic event in AF patients. These patients exhibit complex 
internal characteristics, a variable number of lobes without a 
dominant lobe, and a more irregular shape of the orifice.12) Car-
diac CT with 3D imaging can provide morphological classifi-
cation associated with high-risk peri-procedural complications. 
However, morphological classification alone cannot predict peri-
procedural success in every dynamic intra-cardiac catheter-re-
lated procedure. With this 3D geometric analysis, we can also 
evaluate the relationship between IAS and imaginary LAA ori-
fice planes and LAA long axis alignment. This analysis is im-
portant because the LAA orifice plane is not always perpen-
dicular to the catheter’s direction. Without perpendicularly 
introducing the device mounted on a catheter tip, safe and op-
timal deployment in the LAA is difficult. Application of this 
novel 3D analysis program could be extended to many peri-pro-
cedural situations. The program is easily and conveniently ap-
plied via most commercial analysis workstations commonly 
used for clinical practice and research purposes.
Individualized procedural planning according 
to 3D anatomical structure
Several devices are now used or tested with respect to LAA 
occlusion. Although technical aspects of delivery differ between 
devices, transseptal puncture with a sheath is required to facil-
itate delivery into or around the LAA.17) Typically, the sheath 
is delivered under the guidance of TEE and fluoroscopy. How-
ever, the angle between the IAS and LAA orifice differs by in-
dividual. Moreover, 3D anatomical consideration is not current-
ly possible with conventional methods of device placement. We 
found that the angle between the IAS plane and the line linking 
the LAA orifice center and foramen ovale was significantly dif-
ferent between patients with or without peri-device leakage. A 
larger angle was observed in patients with peri-device leakage, 
suggesting that the additive effects of natural angulation with 
the direction of the advancing puncture needle and catheter 
are related to anatomical mismatch between the LAA and the 
device. Our novel analysis can provide valuable individualized 
pre-operative information to predict post-operative outcomes.
Clinical effects of peri-device leakage
Several reports suggest peri-device leakage after LAA closure 
is benign,4)18)19) but this complication could lead to a negative 
clinical outcome. In the WATCHMAN Left Atrial Append-
age System for Embolic Protection in Patients with Atrial Fi-
brillation (PROTECT-AF) substudy, Viles-Gonzalez et al.4) 
demonstrated that residual peri-device leakage after LAA clo-
sure with a WATCHMAN device was not associated with risk 
of thromboembolic events or increased cardioembolic risk. 
Urena et al.3) also reported that mild peri-device leakage was 
not associated with thromboembolic events after LAA closure 
with ACP. However, these results may not provide sufficient 
evidence because of the studies’ relatively short follow-up du-
ration and low event rate that limited the power of the analy-
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ses. Long-term follow-up is necessary to demonstrate the effect 
of peri-device leakage on clinical outcomes such as cardioem-
bolic events, and complete LAA closure should be attempted. 
Further large cohort study should be needed to clarify the pre-
dictors for the successful result of LAA device closure. Prospec-
tive studies to evaluate not only the relation between 3D ge-
ometry and peri-device leakage, but also the clinical outcome 
according to the LA and LAA geometry might be needed. Fur-
thermore, the prospective study with individualized catheter 
selection, manual shaping of puncture needle or device selection 
may enable the tailored procedure according to their anatomy, 
which might improve the clinical outcome.
Another previous study showed that peri-device leakage was 
not detected at immediate post-procedural status but was ob-
served at the 6-month follow-up TEE,3) indicating different 
mechanisms may exist for earlier and later occurrences of peri-
device leakage. Late occurrence could be due to an under-sized 
device, incomplete device compression, or incomplete endo-
thelization around the device,19)20) whereas earlier occurrence 
may be associated with anatomical mismatch. In our study, peri-
device leakage in most patients was detected during both peri-
procedural and follow-up TEE, which ruled out possible peri-
procedural residual flow due to LAA contraction. We conclude 
that peri-device leakage of our enrolled patients resulted from 
their individual anatomical geometry. Thus, our study is the 
first to suggest anatomical location and internal characteristics 
of the LA and LAA might affect both immediate and delayed 
peri-device leakage.
LA volume and function after LAA exclusion
Volume and function of the LA are crucial because they are 
linked to diastolic function and post-operative cardiovascular 
outcomes.21-25) Some studies have shown that LAA exclusion 
may alter LA compliance, function, or neurohormonal status 
because LAA is a source of atrial natriuretic peptide. However, 
in our study, LAA occlusion altered LA reserve, highlighting 
the need for further investigation incorporating neurohormon-
al markers and 3D-analyzed LA function and geometry. Our 
novel 3D geometrical analysis program could certainly con-
tribute to this analysis.
Study limitations
The present study has several limitations. First, subjects 
were selected from a single-center registry database. The small 
sample size led to a low number of peri-device leakage events, 
and lack of long-term follow-up data made predicting clinical 
outcomes difficult. Secondary, we included patients who un-
derwent either ACP or WATCHMAN device implantation, 
which might affect the incidence of peri-device leakage inde-
pendently of different patient anatomical characteristics. Third-
ly, although we measured geometric parameters using foramen 
ovale, septal puncture site is not guaranteed to match to fora-
men ovale center in actual procedure. Fourthly, we measured 
the LA volume with acquired images at 30% and 70% phase 
of cardiac cycle, which would not matched to systole and dias-
tole of LA in AF patients. 
Conclusion
Morphology of the LA and angles between the IAS and LAA 
orifice measured by 3D CT might be novel anatomical param-
eters for predicting peri-device leakage after LAA device clo-
sure and could identify favorable candidates for the procedure. 
Furthermore, individualizing the procedure based on the pa-
tient’s own anatomical geometry could significantly reduce the 
occurrence of some post-operative cardiovascular complications.
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